60 Results for "

PTX

" in MedChemExpress (MCE) Product Catalog:
Products (60)

60 Results for "PTX" in MCE Product Catalog:

18
18 Publications Verification
Cat. No.: HY-19756
CAS No.: 286936-40-1
Synonyms: Calixarene 0118; PTX008
Target:  

Galectin

Research Areas:  

Cancer

OTX008 is a selective inhibitor of galectin-1.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P71067
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Serum Amyloid P-Component; SAP; 9.5S Alpha-1-Glycoprotein; APCS; PTX2
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P73714
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Pentraxin-related protein PTX3; TSG-14; PTX3; TNFAIP5; TSG14
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P77637
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: C-reactive protein; CRP; PTX1; MGC88244; pentraxin 1; PTX1MGC149895
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P71246
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: alpha-induced protein 5; pentaxin-related gene, rapidly induced by IL-1 beta, tumor necrosis factor; Pentaxin-related protein PTX3; Pentraxin 3; pentraxin 3, long; pentraxin-3; pentraxin-related gene, rapidly induced by IL-1 beta; pentraxin-related protein PTX3;
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-125348
CAS No.: 153212-75-0
Purity:  99.93%
Target:  

Drug Metabolite

Research Areas:  

Cancer

6α-Hydroxy paclitaxel is one of the main metabolites of Paclitaxel (PTX) (HY-B0015), and it is generated by the liver cytochrome P450 enzyme CYP2C8. 6α-Hydroxy paclitaxel has bone marrow toxicity, but it can enhance the cytotoxicity of PTX against leukemia cells without causing cell toxicity. 6α-Hydroxy paclitaxel can be used in leukemia research .
loading...
    loading...
Cat. No.: HY-125348S
CAS No.: 1315376-90-9
Purity:  99.31%
6α-Hydroxy paclitaxel-d5 is the deuterium labeled 6α-Hydroxy paclitaxel. 6α-Hydroxy paclitaxel is one of the main metabolites of Paclitaxel (PTX) (HY-B0015), and it is generated by the liver cytochrome P450 enzyme CYP2C8. 6α-Hydroxy paclitaxel has bone marrow toxicity, but it can enhance the cytotoxicity of PTX against leukemia cells without causing cell toxicity. 6α-Hydroxy paclitaxel can be used in leukemia research.
loading...
    loading...
Cat. No.: HY-111934
CAS No.: 508-77-0
Purity:  97.28%
Cymarin, a cardiac glycoside, potently inhibits the Palytoxin (PTX)-induced K + release (IC50=0.42 μM). Cymarin reveals an antitumor activity against breast cancer and pancreatic cancer. Cymarin exhibits antifeedant and growth inhibitory effects as crop protectant .
loading...
    loading...
Cat. No.: HY-169779
CAS No.: 2376297-69-5
Target:  

p62

Research Areas:  

Cancer

PTX80 is an antagonist of p62 with an IC50 value of 31.18 nM. PTX80 reduces tumor volume in an HCT116 colorectal cancer mouse xenograft model .
loading...
    loading...
Cat. No.: HY-W273690
CAS No.: 1028-33-7
Synonyms: 1-Hexyltheobromine; Hexyltheobromine
Pentifylline (1-Hexyltheobromine; Hexyltheobromine), PTX (HY-B0715) precursor compound, is a vasodilator. Pentifylline decreases procollagen levels and inhibits collagen production. Pentifylline reduces functional nuclear NF-1 to suppress procollagen gene transcription .
loading...
    loading...
Cat. No.: HY-139848
CAS No.: 2891562-77-7
Purity:  98.14%
Target:  

P-glycoprotein

Research Areas:  

Cancer

WS-898 is a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC50 = 5.0, 3.67, and 3.68 nM, respectively).
loading...
    loading...
Cat. No.: HY-P991455

Target:  

TNF Receptor

Research Areas:  

Inflammation/Immunology Cancer

PTX-35 is a costimulatory agonist antibody targeting TNFRSF25 as well as an immune activator that selectively regulates activated CD8 + T cells. PTX-35 enhances the expansion, survival and effector functions of T cells, while reducing the inhibitory activity of regulatory T cells and impairing their stability. PTX-35 exhibits anti-tumor activity, effectively delaying tumor progression and prolonging survival. PTX-35 has a synergistic effect with anti-OX40 agonist antibodies. PTX-35 can be widely used in research on related diseases such as colon cancer and melanoma .
loading...
    loading...
Cat. No.: HY-146034
CAS No.: 2704623-69-6
Research Areas:  

Inflammation/Immunology Cancer

NOD1/2 antagonist-1 (compound 36b) is a potent NOD1/2 (nucleotide-binding oligomerization domain-like receptor 1/2) dual antagonist, with IC50 values of 1.13 (NOD1) and 0.77 μM (NOD2), respectively. NOD1/2 antagonist-1 has a acceptable T1/2 (67.6 min). NOD1/2 antagonist-1 (compound 36b) can improve the antitumor efficacy of Paclitaxel (PTX) .
loading...
    loading...
Cat. No.: HY-178078
CAS No.: 1800077-28-4
Target:  

Drug Intermediate

Research Areas:  

Cancer

PTX-SS-COOH is the proform that can be grafted to the sulfhydryl modified gelatin to form the redox sensitive amphiphilic polymer. The nanoparticle (BSA/Gel-SS-PTX/PTX-SS-COOH NPs) demonstrates an excellent anticancer efficiency. PTX-SS-COOH can be applied in the research of targeted delivery for solid tumors (such as breast cancer and melanoma) by utilizing the unique characteristics of the tumor microenvironment (high GSH level) .
loading...
    loading...
Cat. No.: HY-119833
CAS No.: 73694-15-2
Purity:  99.1%
Rubone, a chalcone analog, is a modulator of miR-34a. Rubone upregulates miR-34a expression in a p53 dependent manner, downregulates the downstream target Bcl-2 and Cyclin D1 expression, and suppresses hepatocellular carcinoma (HCC) growth in vivo. Rubone enhances the anticancer effect of Paclitaxel (PTX; HY-B0015) in PTX-resistant prostate cancer cell lines by reversing the expression of miR-34a downstream targets .
loading...
    loading...
Cat. No.: HY-157529
CAS No.: 2250419-19-1
Research Areas:  

Cancer

IR820-PTX, an IR-820 (HY-136886)-Paclitaxel (HY-B0015) conjugate, is an amphipathic small molecule prodrug. IR820-PTX effectively inhibits tumor growth via combined photothermal therapy (PTT) and chemotherapy .
loading...
    loading...
Cat. No.: HY-P11018
Research Areas:  

Cancer

(123B9)2-L2-PTX is an EphA2-agonistic peptide-drug conjugate (PDC). (123B9)2-L2-PTX consists of a dimeric 123B9 (HY-P10579) and Paclitaxel (HY-B0015). (123B9)2-L2-PTX significantly reduces circulating tumor cells and inhibits lung tumor metastasis in breast-cancer-Metastasis mice model. (123B9)2-L2-PTX can be used for cancers research, such as melanomas and ovarian and breast cancers .
loading...
    loading...
Cat. No.: HY-148750
CAS No.: 1627834-10-9
Synonyms: BD10-2
Target:  

Trk Receptor

Research Areas:  

Neurological Disease

PTX-BD10-2 (BD10-2) is an orally active TrkB/C modulator. PTX-BD10-2 ameliorates BFCN degeneration. PTX-BD10-2 restores cholinergic neurite integrity, alleviates cholinergic neurite atrophy. PTX-BD10-2 can be used in the research of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-177482
CAS No.: 3011748-20-9
Target:  

Drug Intermediate

Research Areas:  

Neurological Disease Cancer

Pro-PTX is a Pd-sensitive Paclitaxel (HY-B0015) prodrug with anticancer activity. Pro-PTX triggers intramolecular cyclization via Pd-catalyzed depropargylation to release active Paclitaxel (HY-B0015) and a non-toxic byproduct. Pro-PTX exhibits low cytotoxicity and antiproliferative activity in cancer cells and non-cancerous human cerebrovascular pericytes. Pro-PTX is applicable for research related to non-small cell lung cancer, glioblastoma and lung cancer .
loading...
    loading...
Cat. No.: HY-171128
CAS No.: 2130882-23-2
PTX-M is an oxidized metabolite of Pentoxifylline (HY-B0715). Pentoxifylline is a phosphodiesterase inhibitor that can be used for the study of peripheral vascular, inflammatory, and immune diseases .
loading...
    loading...